111
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Mycophenolate Mofetil and Sirolimus in Hepatocyte Transplantation in an Experimental Model of Toxic Acute Liver Failure

, , , , , , & show all
Pages 205-213 | Received 11 Jul 2013, Accepted 30 Dec 2013, Published online: 24 Feb 2014

REFERENCES

  • Wesson RN, Cameron AM. Stem cells in acute liver failure. Adv Surg. 2011;45:117–130. Review.
  • Papalois A, Arkadoupoulos N, Pataryas Th, Combined hepatocyte-islet transplantation: an allograft model. Transpl Int. 1994;7(Suppl 1):S432–5.
  • Papalois A, Arkadopoulos N, Kostopanagiotou G, Experimental xenotransplantation of fresh isolated and cryopreserved pig hepatocytes: a biochemical and morphological study. Transplant Proc. 1997 Jun;29(4):2096–8.
  • Fox IJ, Chowdhury JR. Hepatocyte transplantation. Am J Transplant. 2004;4(Suppl 6):7–13.
  • Fisher RA, Bu D, Thompson M, Wolfe L, Ritter JK. Optimization of conditions for clinical human hepatocyte infusion. Cell Transplant. 2004;13(6):677–689.
  • Krishna Vanaja D, Sivakumar B, Jesudasan RA, In vivo identification, survival, and functional efficacy of transplanted hepatocytes in acute liver failure mice modelby FISH. Cell Transplant. 1998;7(3):267–273.
  • Magee P The metabolism of dimethylnitrosamine. Biochem J. 1956;64:676.
  • Tenant. Evaluation of the trypan blue technique for determination of cell viability. J Transplant. 1964;2(6): 685–694.
  • Guha C, Parashar B, Deb NJ, Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology. 2002 Aug;36(2):354–362.
  • Park SM, Vo K, Lallier M, Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease. Cell Transplant. 2006;15(1):13–22.
  • Kocken JM, Borel Rinkes IH, Bijma AM, Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model. Transplantation. 1996;62(3):358–364.
  • Mitry RR, Hughes RD, Aw MM, Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 2003;12(1):69–74.
  • Mitry RR, Dhawan A, Hughes RD, One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation. 2004;77(10):1614–1616.
  • Dan YY, Riehle KJ, Lazaro C, Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci USA. 2006;103(26):9912–9917. Epub 2006 Jun 16.
  • Avital I, Feraresso C, Aoki T, Bone marrow-derived liver stem cell and mature hepatocyte engraftment in livers undergoing rejection. Surgery. 2002;132(2):384–390.
  • Schwerfeld-Bohr J, Chi H, Worm K, Influence of hematopoietic stem cell-derived hepatocytes on liver regeneration after sex-mismatched liver transplantation in humans. J Invest Surg. 2012 Aug;25(4):220–226. doi: 10.3109 /08941939.2011.627088. Epub 2012 May 9.
  • Palmes D, Qayumi AK, Spiegel HU. Liver bridging techniques in the treatment of acute liver failure. J Invest Surg. 2000;13(6):299–311.
  • Pareja E, Gomez-Lechon MJ, Cortes M, Human hepatocyte transplantation in patients with hepatic failure awaiting a graft. Eur Surg Res. 2013;50(3-4):273–281. doi: 10.1159 /000351332. Epub 2013 Jun 18.
  • Tsiolis I, Papalois A, Loukopoulos I, Experimental isolation and transplantation of hepatocytes with the use of antibody against interleukin-2 receptor (daclizumab) as immunosuppressive agent. Transplant Proc. 2005;37(4):1929–1930.
  • Kontalexis S, Papalois A, Bibidakis E, Use of mycophenolate mofetil in the experimental allo-transplantation of hepatocytes in rats with fulminant hepatic failure. Transplant Proc. 2004;36(6):1739–1740.
  • Wu SL, Pan CE, Yu L, Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model. Transplant Proc. 2005 Jun;37(5): 2354–2359.
  • Wu YM, Joseph B, Gupta S. Immunosuppression using the mTOR inhibition mechanism affects replacement of rat liver with transplanted cells. Hepatology. 2006;44(2): 410–419.
  • Stepkowski SM. Preclinical results of sirolimus treatment in transplant models. Transplant Proc. 2003;35(3 Suppl):219S–226S.
  • Fitzpatrick E, Mitry RR, Dhawan A. Human hepatocyte transplantation: State of the art. J Intern Med. 2009 Oct;266(4):339–357.
  • Arkadopoulos N, Papalois A, Pataryas TH, Experimental transplantation of hepatocytes in cases of toxic acute liver failure. An allograft model. Transpl Int. 1994;7(Suppl 1):S171–S174.
  • Lytras D, Papalois A, Tsaroucha AK, Xenotransplantation of hepatocytes in rats with acute liver failure using sirolimus for immunosuppression. J Int Med Res. 2010;38(2):546–557.
  • Ginesta MM, Mollevi DG, Serrano T, Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model. APMIS. 2003;111(3):371–381.
  • Newsome PN, Plevris JN, Nelson LJ, Animal models of fulminant hepatic failure: A critical evaluation. Liver Transpl. 2000;6(1):21–31. Review.
  • Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci. 1991;36(6):770–774. Review.
  • Guha C, Sharma A, Gupta S, Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res. 1999;59(23):5871–5874.
  • Hughes RD, Mitry RR, Dhawan A. Current status of hepatocyte transplantation. Transplantation. 2012 Feb 27; 93(4):342–7.
  • Krause P, Wolff HA, Rave-Frank M, Fractionated external beam radiotherapy as a suitable preparative regimen for hepatocyte transplantation after partial hepatectomy. Int J Radiat Oncol Biol Phys. 2011; 80(4):1214–1219. Epub 2011 Apr 20.
  • Bonavita AG, Quaresma K, Cotta-de-Almeida V, Pinto MA, Hepatocyte xenotransplantation for treating liver disease. Xenotransplantation. 2010 May–Jun;17(3):181–7.
  • Mei J, Sgroi A, Mai G, Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant. 2009;18(1):101–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.